Publication | Closed Access

Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline

Neuro-oncologyNeurodegenerative DiseasesChemoprevention StrategyType BMedicineCell DeathNeuropharmacologyA Monoamine OxidaseNeuroprotectionNeurologyNeuroscienceAnti-cancer AgentGene ExpressionPharmacologyGliomaNeuroinflammation